相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors
Eric Angevin et al.
CLINICAL CANCER RESEARCH (2014)
Current therapy of myelodysplastic syndromes
Amer M. Zeidan et al.
BLOOD REVIEWS (2013)
A Phase I, Open-Label Study of Siltuximab, an Anti-IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease
Razelle Kurzrock et al.
CLINICAL CANCER RESEARCH (2013)
Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
Katie Stone et al.
PLOS ONE (2013)
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
Rami S. Komrokji et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Interleukin-6 and Interleukin-1 enhancement of GM-CSF-dependent proliferation of haematopoietic progenitor cells in myelodysplastic syndromes
Martin R. Schipperus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome
Maria L. H. Cuijpers et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
Tanya B. Dorff et al.
CLINICAL CANCER RESEARCH (2010)
Siltuximab, a Novel Anti-Interleukin-6 Monoclonal Antibody, for Castleman's Disease
Frits van Rhee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Billy Andriopoulos et al.
NATURE GENETICS (2009)
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes
R Tehranchi et al.
BLOOD (2005)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
E Nemeth et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome
E Flores-Figueroa et al.
LEUKEMIA RESEARCH (2002)
Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome
K Allampallam et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome
HC Hsu et al.
ONCOLOGY (2002)
In vivo production of cytokines by bone marrow stromal cells and macrophages from patients with myelodysplastic syndrome
TE Manakova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2001)
分享论文
